Figures & data
Figure 1. (A) Illustration of CPP mediated RBCs encapsulation technology (He et al., Citation2014). (B) The morphology of untreated normal RBCs and LMWP-ASNase-encapsulated RBCs by scanning electron microscopic images. (C) Pharmacokinetic profiles of ASNase in DBA2 mice and Kaplan–Meier survival curve for DBA/2 mice bearing L5178Y lymphoma cells (Kwon et al., Citation2009).
Figure 2. Schematic representation of process of leukocyte transmigration endothelium under inflammation.
Figure 3. (A) Alexa Fluor 680-labeled BMMs loaded with nanozyme. (B) Alexa Fluor 680-labeled nanozyme administered alone (Brynskikh et al., Citation2010).
Figure 4. (A) NPs absorbed onto RBCs surface by no-covalent coupling (Chambers & Mitragotri, Citation2004). (B) Covalently coupled NPs onto T-cell membrane via thiol-maleimide conjugation (Stephan et al., Citation2010). (C) NPs internalization by macrophages (Choi et al., Citation2012).
Figure 5. Schematic representation of the preparation process of the RBC-membrane-coated PLGA NPs (Hu et al., Citation2012).
